6th Annual Advances in Chemical Sciences Symposium
May 8, 2017
CreaGen & C2I's CEO/Co-founder Recieves 2018 Henry A. Hill Award
November 26, 2018
Frequency Therapeutics Welcome!
March 1, 2016
CreaGen Life Science Incubator team wishes a warm welcome to our new resident, Frequency Therapeutics! We are excited to have your team joining our incubator family.
Frequency Therapeutics is a platform technology that is based on discoveries in stem cell biology by Robert S. Langer at MIT and Jeff Karp at Harvard Medical School. Frequency Therapeutics initial focus is on chronic hearing loss, a potential $10B+ US market with no effective therapeutic solution. Other potential applications include gastrointestinal diseases and diabetes.